M., Niccum, D., Dunitz, J
In certain embodiments, the increase in exposure of an active agent and the increase in the length of time that the concentration of the active agent is above C min by a controlled-release otic formulation described herein is greater than 100% compared to a formulation that is not a controlled-release otic formulation
Tattersall AB, Bridgman KM, Huitson A
Patients with COQ4 mutations may benefit from coenzyme Q10 supplementation, while those with PDSS2 , COQ8A , and COQ9 mutations tend to respond less effectively
It is most effectively utilized in combination with other lightening products, but definitely plays an important role in the treatment of dark spots
PubChem compound record Khavinson VK, Bondarev IE, Butyugov AA